1]Stokin GB, Lillo C, Falzone TL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer,s disease[J]. Science, 2005, 307 (5713): 1282-1288.
[2]Savva GM, Wharton SB, Ince PG, et al. Age, neuropathology, and dementia[J]. N Engl J Med, 2009, 360 (22): 2302-2309.
[3]Iqbal K,Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and
prevention[J]. J Cell Mol Med, 2008, 12 (1): 38-55.
[4]Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer.s disease: follow-up of a
randomised, placebo-controlled phase I trial[J]. Lancet, 2008, 372 (9634): 216-223.
[5]Mattson MP. Pathways towards and away from Alzheimer,s disease[J]. Nature, 2004, 430 (7000): 631-639.
[6]Golub MS,Keen CL. Effects of dietary aluminum on pubertal mice[J]. Neurotoxicol Teratol, 1999, 21 (5): 595-602.
[7]Ribes D, Colomina MT, Vicens P, et al. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic
mouse model of Alzheimer,s disease[J]. Exp Neurol, 2008, 214 (2): 293-300.
[8]Laczo J, Vlcek K, Vyhnalek M, et al. Spatial navigation testing discriminates two types of amnestic mild cognitive
impairment[J]. Behav Brain Res, 2009, 202 (2): 252-259.
[9]Reinhard C, Hebert SS,De Strooper B. The amyloid-beta precursor protein: integrating structure with biological function
[J]. EMBO J, 2005, 24 (23): 3996-4006.
[10]Dawson GR, Seabrook GR, Zheng H, et al. Age-related cognitive deficits, impaired long-term potentiation and reduction
in synaptic marker density in mice lacking the beta-amyloid precursor protein[J]. Neuroscience, 1999, 90 (1): 1-13.
[11]Frisardi V, Solfrizzi V, Capurso C, et al. Aluminum in the diet and Alzheimer,s disease: from current epidemiology to
possible disease-modifying treatment[J]. J Alzheimers Dis, 2010, 20 (1): 17-30.
[12]Lin R, Chen X, Li W, et al. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by
curcumin[J]. Neurosci Lett, 2008, 440 (3): 344-347.
[13]Tanino H, Shimohama S, Sasaki Y, et al. Increase in phospholipase C-delta1 protein levels in aluminum-treated rat brains
[J]. Biochem Biophys Res Commun, 2000, 271 (3): 620-625.
[14]Steinbrecher KA, Wilson W, Cogswell PC, et al. Glycogen synthase kinase 3beta functions to specify gene-specific,
NF-kappaB-dependent transcription[J]. Mol Cell Biol, 2005, 25 (19): 8444-8455.
[15]Liu SJ, Zhang AH, Li HL, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase
and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory[J]. J Neurochem, 2003, 87
(6): 1333-1344.
[16]Zeng YQ, Chen XCh, Huang Ch, et al. The attenuation of β-amyloid peptide25-35 -induced tau hyperphosporylation in cortical
neurons by the regulation of ginsenoside Rg1 on the activity of GSK-3β and PP2A[J]. Acta Anatomica Sinica, 2007, 38
(6): 665-670.(in Chinese)
曾育琦, 陈晓春, 黄春, 等. 人参皂苷Rg1通过调节GSK-3β/PP2A活性减轻皮层神经元Tau蛋白过度磷酸化[J]. 解剖学报, 2007, 38
(6): 665-670.
[17]Tomljenovic L. Aluminum and Alzheimer,s disease: after a century of controversy, is there a plausible link[J]? J
Alzheimers Dis, 2011, 23 (4): 567-598. |